Transitional cell carcinoma differential diagnosis

Jump to navigation Jump to search

Transitional cell carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Transitional cell carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Cystoscopy and Bladder Biopsy

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Transitional cell carcinoma differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Transitional cell carcinoma differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Transitional cell carcinoma differential diagnosis

CDC on Transitional cell carcinoma differential diagnosis

Transitional cell carcinoma differential diagnosis in the news

Blogs on Transitional cell carcinoma differential diagnosis

Directions to Hospitals Treating Transitional cell carcinoma

Risk calculators and risk factors for Transitional cell carcinoma differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Transitional cell carcinoma of bladder must be differentiated from squamous cell carcinoma of the bladder, adenocarcinoma of the bladder renal cancer, renal stones, prostate cancer, and cystitis. Transitional cell carcinoma of renal pelvis must be differentiated from renal cell carcinoma, kidney metastasis, renal medullary carcinoma, renal lymphoma

Differential Diagnosis

Transitional cell carcinoma of bladder

Transitional cell carcinoma of bladder must be differentiated from:*Squamous cell carcinoma of the bladder

Transitional cell carcinoma of renal pelvis

Transitional cell carcinoma of renal pelvis must be differentiated from:

Filling defect within renal pelvis/dilated calyx

  • Renal stone:
  • Usually significantly higher attenuating
  • Non-enhancing
  • Blood clot:
  • May be similar in attenuation (blood clot is usually a little higher)
  • Does not enhance
  • Changes configuration on short term follow up
  • Pyelitis cystica
  • Renal tuberculosis
  • Papillary necrosis

Distortion or obliteration of calices by renal mass

  • Renal cell carcinoma
  • Often more vascular and thus more enhancing
  • Tends to distort the renal outline
  • Kidney metastasis
  • Renal medullary carcinoma
  • Renal lymphoma
  • Renal abscess
  • Focal xanthogranulomatous pyelonephritis
  • Renal tuberculosis

References

Template:WH Template:WS